关键词: CMS Centers for Medicare & Medicaid Services HRSA Health Resources and Services Administration OPO deceased donation organ procurement organ procurement organization policy

Mesh : Humans United States Tissue and Organ Procurement Tissue Donors Benchmarking

来  源:   DOI:10.1016/j.ajt.2023.08.020   PDF(Pubmed)

Abstract:
With stakeholder focus on the United States organ procurement system, there is a need for tools that permit comparative assessment of organ procurement providers. We developed a public-facing dashboard for organ procurement organizations (OPOs), using data from multiple sources, to create an online, readily accessible visualization of OPO practice conditions and performance for the period 2010-2020. With this tool, OPOs can be compared on the CMS metric of donors procured per 100 donation-consistent deaths, as well as donation after circulatory death procurement, procurement of older and minority patient populations, procurement in smaller hospitals, and procurement of patients without a significant drug history. Patterns of higher performance were identified, and 74% of differences in overall donor procurement rates could be explained using model variables. Procurement differences were affected to a greater and more reproducible degree by OPO performance among Black and non-White patient populations, as well as in smaller hospitals, than by donation service area characteristics. Dashboards such as ours support OPOs and stakeholders in quality improvement actions, through leveraging benchmarked performance data among organ procurement clinical providers.
摘要:
由于利益相关者关注美国器官采购系统,需要能够对器官采购提供者进行比较评估的工具。我们为器官采购组织(OPO)开发了一个面向公众的仪表板,使用来自多个来源的数据,创建一个在线,2010-2020年期间OPO实践条件和性能的可视化。有了这个工具,OPO可以在每100例捐赠一致死亡的捐赠者的CMS指标上进行比较,以及循环系统死亡后捐赠(DCD)采购,采购老年人和少数民族患者群体,在较小的医院采购,并采购无明显用药史的患者。确定了更高性能的模式,总体捐助者采购率差异的74%可以用模型变量来解释。黑人和非白人患者人群中的OPO表现对采购差异的影响更大,更可重复。以及在较小的医院,而不是按捐赠服务区(DSA)的特点。像我们这样的仪表板在质量改进行动中支持OPO和利益相关者,通过利用器官采购临床提供商之间的基准性能数据。
公众号